CoaguChek® Vantus

IVD For in vitro diagnostic use.
CoaguChek Vantus

The future of INR self-testing

Trust in your patients’ self-testing results like never before. Accurate INR results are transmitted wirelessly via Bluetooth®-enabled CoaguChek® Vantus and can help improve patient compliance versus clinic-based testing, which may increase time in therapeutic range (TTR), and enable therapy decisions based on current results.1,2,3

CoaguChek Vantus
Benefits at a glance

Benefits at a glance

Related categories

Training and support

Training and support

Use left and right arrow keys to scroll between the tabs

Overview

Ordering information

Technical documents

multilangimg
   
Document repository
error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later

Related products

...
    ...

    Contact us

    Do you have any questions about our products or services? We’re here to help. Fill out the form to have a Roche representative contact you.

    References

    1. Bluetooth connectivity requires a smartphone or tablet. Minimum specifications required.
    2. Kortke, H., Minami, K., Reymann, T., et al., (2001). “INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial).” Z Kardiol 90(6)118-124.
    3. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Meats E and Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367:404-411

    Call 1-800-428-4674 for a list of supported devices and operating systems.